96 filings
Page 2 of 5
8-K
q98o24slfmfc
22 Dec 22
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
8:04am
8-K
4xjm9fqkgwognefg1w
3 Nov 22
Collegium Reports Third Quarter 2022 Financial Results
4:01pm
8-K
mfvl87t
4 Aug 22
Collegium Reports Second Quarter 2022 Financial Results
4:01pm
8-K
44a3g2
23 May 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K/A
09j2a69dxb 02c
13 May 22
Financial Statements and Exhibits
4:01pm
8-K
7ybbzjz1dq
10 May 22
Collegium Reports First Quarter 2022 Financial Results
4:01pm
8-K
4txek
13 Apr 22
Regulation FD Disclosure
8:00am
8-K
kvucnop5bwaituozx3n
6 Apr 22
Departure of Directors or Certain Officers
8:10am
8-K
hfrcrr8grlcc6duz
5 Apr 22
Regulation FD Disclosure
8:05am
8-K
xaf e5nyr
23 Mar 22
Collegium Completes the Acquisition of BDSI
7:55am
8-K
4pjmky3g1sm2cvc7j9
24 Feb 22
Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results
4:01pm
8-K
vwqtuaoi9u
14 Feb 22
Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio
7:42am
8-K
jmomff
28 Dec 21
Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation
8:01am
8-K
djm tnjazu9t7a1iaku
12 Nov 21
Cost Associated with Exit or Disposal Activities
8:00am
8-K
ivtf43u
4 Nov 21
Collegium Reports Third Quarter Fiscal 2021 Results
4:01pm
8-K
pa1t6zsslq
30 Sep 21
Departure of Directors or Certain Officers
5:10pm
8-K
tlo m4r8e5hz
16 Aug 21
Other Events
8:00am
8-K
0wlpktjp91
5 Aug 21
Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million
4:03pm
8-K
sqxk2
2 Jun 21
Regulation FD Disclosure
4:02pm
8-K
b2m td7tj00
24 May 21
Departure of Directors or Certain Officers
4:01pm